GRAIL’s return to Illumina, the world’s biggest gene-sequencing firm, is intriguing for three reasons
-2 genome at the start of the covid-19 pandemic. Using technology acquired with the purchase in 2007 of Solexa, a British company, it provides gene-sequencing tools to genomics companies, including those developing liquid biopsies or blood tests for cancer. Mr deSouza reckons that the global market for cancer gene-sequencing could be worth $75bn by 2035. That looks promising for a gene-sequencing provider. Even more so ifcan change the efficacy and economics of cancer care.
The antitrust concerns can be viewed narrowly or broadly. From a narrow perspective, customers of Illumina who hope to compete within testing may worry that Illumina will charge them higher prices for sequencers. That could give, if it has lower sequencing costs, an edge. Illumina counters that it has no incentive to harm its clients, because it makes much more money selling sequencers than it does selling tests. It has also pledged to supply sequencers to them on the same terms as it does to.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Apple wins antitrust challenge as judge rules commissions don’t violate lawA federal judge sided with Apple on Friday, finding the iPhone-maker’s developer restrictions and 30% commission for digital goods and services don’t violate the antitrust law
Baca lebih lajut »
Quit Google Chrome For One Of These 3 Privacy-Friendly AlternativesGoogle Chrome is too data-hungry and powerful. Here are 3 privacy-friendly alternatives.
Baca lebih lajut »
Inside DeepMind's secret plot to break away from GoogleBusiness Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Baca lebih lajut »
Analysis: Epic's narrow win in App Store case toughens fight against Google Play rulesAndroid app makers suing to stop Alphabet Inc's Google from siphoning up to 30% of their sales received little reassurance about their chances on Friday as a judge allowed a comparable fee charged by Apple Inc to stand.
Baca lebih lajut »